Comparison of outcome endpoints in intermediate- and high-risk prostate cancer after combined-modality radiotherapy

Andreas Boehle^*, Katharina Katic, Inke R. König, Irina Robrahn-Nitschke, Bernd Brandenburg

^*Korrespondierende/r Autor/-in für diese Arbeit